Nanobiotix S A 's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Nanobiotix S A 's ROA in the fourth quarter of 2025?
Nanobiotix S A recorded a cumulative net loss of $-27 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -35.05%.

However, within the Healthcare sector 535 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 4366.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Total Assets Change	0.51 %	0.51 %	4.04 %	0.51 %	-28.2 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-27	-76	-76	-76	-76
Return On Assets (TTM)	-35.05 %	-99.8 %	-99.92 %	-100.93 %	-101.06 %
NBTX's Total Ranking	# 4366	#	#	#	# 5220
Total Assets (TTM) in million	76	76	79	76	76
Seq. Total Assets Change	0 %	-3.4 %	3.52 %	0.51 %	0 %
Seq. Net Income Change	-	-	-	-	-

NBTX's 5 Years Annual ROA >> Back to NBTX Management Effectiveness >> Compare NBTX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 217
Sector	# 536
Overall	# 4328

Return On Assets Statistics
High	Average	Low
-35.36 %	-64.06 %	-101.06 %
(Dec 31 2025)		(Dec 31 2024)

Financial Statements
Nanobiotix S A 's Assets	$ 76 million	NBTX's Balance sheet
Nanobiotix S A 's Income	$ -27 million	Quarterly NBTX's Income Statement
NBTX's Income by Division		See NBTX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	0.51 %	-28.2 %	57.1 %	-41.27 %	-24.07 %
Total Assets in million	76	76	105	67	114
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-27	-76	-44	-64	-53
Annual Return On Assets	-35.36 %	-101.06 %	-42.28 %	-95.44 %	-46.19 %

NBTX's 5 Years Annual ROA >> Back to NBTX Management Effectiveness >> Compare NBTX ROA to its Competitors

More Return On Assets Ratios
NBTX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NBTX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NBTX's Competitors
Subscribers only: Roa for Nanobiotix S A 's Suppliers
Subscribers only: Return On Assets for NBTX's Customers

You may also want to know
NBTX's Roi	NBTX's Inventory Turnover Ratio	NBTX's Growth Rates	NBTX's Dividend Comparisons
	NBTX's Profitability Ratios	NBTX's Asset Turnover Ratio	NBTX's Dividend Growth
NBTX's Roe	NBTX's Valuation Ratios	NBTX's Financial Strength Ratios	NBTX's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector

ROA

Date modified: 2026-09-18T13:11:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.